Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-apa Cpd
2. Aminopenicillanic Acid
3. Aminopenicillanic Acid, Potassium Salt
4. Aminopenicillanic Acid, Sodium Salt
1. 551-16-6
2. 6-apa
3. Penicin
4. Penin
5. Aminopenicillanic Acid
6. 6-aps
7. (2s,5r,6r)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
8. Phenacyl 6-aminopenicillinate
9. 6-aminopenicillamine Acid
10. (+)-6-aminopenicillanic Acid
11. 6-aminopenicillanate
12. Ai3-52557
13. Chebi:16705
14. 6-amino-penicillanic Acid
15. Mfcd00005176
16. Qr0c4r7xvn
17. 6beta-aminopenicillanic Acid
18. (2s,5r,6r)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptan-2-carbonsaeure
19. Chembl1236749
20. 6-amino-2,2-dimethylpenam-3alpha-carboxylic Acid
21. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-amino-3,3-dimethyl-7-oxo-, (2s,5r,6r)-
22. Sr-01000640154-1
23. 6-aminopenicillanicacid
24. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, 6-amino-3,3-dimethyl-7-oxo-, (2s,5r,6r)-
25. Einecs 208-993-4
26. Unii-qr0c4r7xvn
27. Nsc 50071
28. Nsc-50071
29. Ncgc00160198-01
30. (2s,5r,6r)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid
31. (2s,5r,6r)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid (6-aminopenicillanic Acid)
32. Amino Penicillanic Acid
33. 6-aminopenicillanic-acid
34. 6-aminopenici Llanic Acid
35. Bmse000312
36. Epitope Id:117703
37. Ec 208-993-4
38. Dsstox_cid_26097
39. Dsstox_rid_81336
40. Dsstox_gsid_46097
41. Schembl66332
42. Amoxicillin Related Compound A
43. Dtxsid7046097
44. 09070_fluka
45. 6-aminopenicillinic Acid (6-apa)
46. Bcp13375
47. Str03060
48. Zinc3860188
49. Tox21_111749
50. Bdbm50420257
51. Ccg-50809
52. S5035
53. (+)-6-aminopenicillanic Acid, 96%
54. 6-aminopenicillanic Acid [mi]
55. Akos015907713
56. Cs-w014265
57. Hy-w013549
58. Ks-5277
59. S12351
60. Ac-11282
61. Cas-551-16-6
62. Ampicillin Impurity A [ep Impurity]
63. Piperacillin Sodium Impurity H [ep]
64. A0800
65. Amoxicillin Related Compound A [usp-rs]
66. C02954
67. (+)-6-aminopenicillanic Acid, Analytical Standard
68. A830497
69. Sulbactam Sodium Impurity B [ep Impurity]
70. Amoxicillin Sodium Impurity A [ep Impurity]
71. Cloxacillin Sodium Impurity C [ep Impurity]
72. Q2823234
73. W-105586
74. 6beta-amino-2,2-dimethylpenam-3alpha-carboxylic Acid
75. Amoxicillin Related Compound A [usp Impurity]
76. Amoxicillin Trihydrate Impurity A [ep Impurity]
77. Ampicillin Trihydrate Impurity A [ep Impurity]
78. Dicloxacillin Sodium Impurity C [ep Impurity]
79. Benzylpenicillin Sodium Impurity A [ep Impurity]
80. Phenoxymethylpenicillin Impurity C [ep Impurity]
81. Z1741972222
82. (3s,5r,6r)-6-amino-2,2-dimethylpenam-3-carboxylic Acid
83. Benzylpenicillin Potassium Impurity A [ep Impurity]
84. (3s, 5r, 6r)-6-amino-2,2-dimethylpenam-3-carboxylic Acid
85. Oxacillin Sodium Monohydrate Impurity A [ep Impurity]
86. Phenoxymethylpenicillin Potassium Impurity C [ep Impurity]
87. Flucloxacillin Impurity C, European Pharmacopoeia (ep) Reference Standard
88. (2s)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
89. Amoxicillin Related Compound A, United States Pharmacopeia (usp) Reference Standard
90. (2s,5r,6r)-(+)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
91. (2s,5r,6r)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid
92. [2s-(2alpha,5alpha,6beta)]-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
93. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, 6-amino-3,3-dimethyl-7-oxo-, (2s,6r)-
94. 6-apa (2s,5r,6r)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Penicin Penin
95. Rel-(2r,6s)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
96. X1e
| Molecular Weight | 216.26 g/mol |
|---|---|
| Molecular Formula | C8H12N2O3S |
| XLogP3 | -2.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 1 |
| Exact Mass | 216.05686342 g/mol |
| Monoisotopic Mass | 216.05686342 g/mol |
| Topological Polar Surface Area | 109 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 318 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21994
Submission : 2008-09-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27248
Submission : 2013-06-04
Status : Active
Type : II
NDC Package Code : 52115-000
Start Marketing Date : 2013-06-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30779
Submission : 2016-08-02
Status : Active
Type : II
NDC Package Code : 55657-100
Start Marketing Date : 2005-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18525
Submission : 2005-11-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19525
Submission : 2006-06-19
Status : Active
Type : II
NDC Package Code : 32903-045
Start Marketing Date : 2005-03-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32467
Submission : 2017-12-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17197
Submission : 2004-02-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22393
Submission : 2008-12-31
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17694
Submission : 2004-09-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21932
Submission : 2008-08-25
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10139
Submission : 1968-06-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 1520
Submission : 1970-04-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5887
Submission : 1985-06-05
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2246
Submission : 1974-03-05
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11167
Submission : 1994-10-26
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8757
Submission : 1990-09-25
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9799
Submission : 1990-07-11
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5143
Submission : 1983-11-16
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
NDC Package Code : 59651-991
Start Marketing Date : 2024-08-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 32903-045
Start Marketing Date : 2005-03-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 55657-100
Start Marketing Date : 2005-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52115-000
Start Marketing Date : 2013-06-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
About the Company : CSPC Pharmaceutical Group Limited ("CSPC") (Stock code: 1093. HK) is a leading pharmaceutical group in China. It was established in 1997. Since the very beginning, CSPC has taken ...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
DATA COMPILATION #PharmaFlow
https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
Market Place
APIs
Reply
10 Dec 2022
Reply
28 Jul 2020
Reply
05 Sep 2016
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
INTERMEDIATES
Reply
11 Nov 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
A 6-Aminopenicillanic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 6-Aminopenicillanic Acid, including repackagers and relabelers. The FDA regulates 6-Aminopenicillanic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 6-Aminopenicillanic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 6-Aminopenicillanic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 6-Aminopenicillanic Acid supplier is an individual or a company that provides 6-Aminopenicillanic Acid active pharmaceutical ingredient (API) or 6-Aminopenicillanic Acid finished formulations upon request. The 6-Aminopenicillanic Acid suppliers may include 6-Aminopenicillanic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of 6-Aminopenicillanic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 6-Aminopenicillanic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of 6-Aminopenicillanic Acid active pharmaceutical ingredient (API) in detail. Different forms of 6-Aminopenicillanic Acid DMFs exist exist since differing nations have different regulations, such as 6-Aminopenicillanic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 6-Aminopenicillanic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. 6-Aminopenicillanic Acid USDMF includes data on 6-Aminopenicillanic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 6-Aminopenicillanic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 6-Aminopenicillanic Acid suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 6-Aminopenicillanic Acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 6-Aminopenicillanic Acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 6-Aminopenicillanic Acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 6-Aminopenicillanic Acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 6-Aminopenicillanic Acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 6-Aminopenicillanic Acid suppliers with NDC on PharmaCompass.
6-Aminopenicillanic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 6-Aminopenicillanic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 6-Aminopenicillanic Acid GMP manufacturer or 6-Aminopenicillanic Acid GMP API supplier for your needs.
A 6-Aminopenicillanic Acid CoA (Certificate of Analysis) is a formal document that attests to 6-Aminopenicillanic Acid's compliance with 6-Aminopenicillanic Acid specifications and serves as a tool for batch-level quality control.
6-Aminopenicillanic Acid CoA mostly includes findings from lab analyses of a specific batch. For each 6-Aminopenicillanic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
6-Aminopenicillanic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (6-Aminopenicillanic Acid EP), 6-Aminopenicillanic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (6-Aminopenicillanic Acid USP).
LOOKING FOR A SUPPLIER?
Share
Comment (6)
